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ABSTRACT
Objectives: To adapt the Components of Primary Care Index (CPCI) to be
applicable to oncology outpatients and to assess the reliability and validity
of the adapted instrument (renamed the Medical Care Questionnaire
[MCQ]).
Methods: The development and validation of the MCQ took place in four
phases. Phase 1 reviewed the literature and examined existing measures. In
Phase 2, the selected instrument (CPCI) was reviewed by a panel of experts
using a stepwise consensus procedure. In Phase 3, the adapted 21-item
MCQ was administered to 200 outpatients attending oncology appoint-
ments. The instrument was reﬁned to 15 items and in Phase 4, it was
completed by 477 oncology outpatients. The psychometric properties of
the new instrument were assessed using exploratory factor analysis (EFA),
conﬁrmatory factor analysis, multitrait scaling analysis, and by comparing
MCQ scores between known groups.
Results: EFA of the 15-item MCQ suggested three subscales with accept-
able to good reliability: “Communication” a = 0.69; “Coordination”
a = 0.84; and “Preferences” a = 0.75. Comparing known groups showed
that patients who saw fewer doctors during their clinic visits reported
stronger “Preferences” to see their usual doctor and rated “Communica-
tion” with their doctors as better than patients who saw more doctors
during their clinic visits.
Conclusion: The MCQ demonstrates good psychometric properties in the
target population. It is a brief and simple-to-use instrument, which pro-
vides a valid perspective on patients’ experiences of communicating with
doctors and their perceptions of the continuity and coordination of their
cancer care.
Keywords: cancer, communication, patient-reported outcomes, psycho-
metric properties, questionnaire development.
Introduction
In the late 1990s, hospital-based oncology practices began to
change with the development of new and effective systemic
cancer treatments. The delivery of cancer care became more
complex with increasing number of patients surviving for longer
and increasing number of oncologists and nurses being involved
in the care delivery. Multidisciplinary teams were formed to
ensure involvement of the necessary experts in diagnosis, treat-
ment modalities, and patient care, so that all patients received
consistently high quality and timely treatment. Such multidisci-
plinary and team-based structures are common within UK
hospitals for the delivery of a variety of medical interventions.
Nevertheless, the involvement of a large number of medical staff
for each patient can have a negative impact on the continuity of
care that patients receive if medical staff vary in their ability to
elicit important symptoms or functional limitations, to assess
change over time, or to make an objective medical record of
problems [1–3]. Continuity of care is an important issue for
modern health service provision, yet assessing continuity is not
always straightforward, in part because it has been a difﬁcult
subject to deﬁne.
Early deﬁnitions described good continuity of care quantita-
tively as a succession of visits by a patient to the same health-care
provider [4]. More recent deﬁnitions have made attempts to
evaluate continuity of care within the context of a multidisci-
plinary and multiservice health system. As part of a National
Health Service (NHS) scoping exercise, Freeman et al. [5] iden-
tiﬁed three aspects of health care that were considered important
to continuity of care: seeing the same health-care provider over
time; having continuity when care is shared or transferred
between health-care providers; and having continuity of infor-
mation across medical records and providers. Continuity of care
is expected to have an impact on the quality of care that patients
receive and may improve patient outcomes. For example, higher
experienced continuity may be associated with lower health-care
needs in the future [6]. Nevertheless, it can be difﬁcult to elicit
reliable self-reports of patients’ perceptions of the care they
receive. For example, in oncology, patients tend to report high
levels of satisfaction with their care and appear reluctant to rate
their medical team negatively [7]. Therefore, measuring satisfac-
tion with care may not offer a true reﬂection of patients’ expe-
riences of the continuity of their care.
Within the context of changes to patient care and manage-
ment in oncology during the late 1990s, we wished to examine
patients’ perceptions of the continuity of their care. Nevertheless,
at this time there were no cancer-speciﬁc instruments suitable for
measuring continuity of care in secondary/tertiary health ser-
vices. As such, we adapted an existing instrument that assessed
continuity of care in the primary health-care setting. Over several
years, we have continued to develop this instrument and have
used it in randomized trials to document patients’ experiences of
the continuity of their care. In this article, we present data
showing the development and psychometric validity of the
Medical Care Questionnaire (MCQ).
Address correspondence to: Clare Harley, Room 142, Level 3, Bexley
Wing, St James’s Institute of Oncology, St James’ University Hospital,
Beckett Street, Leeds, LS9 7TF, UK. E-mail: c.harley@leeds.ac.uk
10.1111/j.1524-4733.2009.00574.x
Volume 12 • Number 8 • 2009
V A L U E I N H E A LT H
1180 © 2009, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 1098-3015/09/1180 1180–1186
Methods
The development of the MCQ was carried out in four phases.
Phase 1 was a literature review to determine whether existing
instruments could be used or adapted for outpatient oncology.
Phase 2 included modiﬁcation of an existing instrument (Com-
ponents of Primary Care Index [CPCI]) [8] by expert review.
Phase 3 was a pilot study to explore the psychometric properties
of the reﬁned instrument in a patient population. The results of
Phase 3 suggested further modiﬁcation of the instrument, so
Phase 4 examined the validity of the instrument in a larger
patient sample. Each phase was carried out sequentially and data
for Phases 3 and 4 were collected from the same medical oncol-
ogy outpatient clinic. Table 1 summarizes the aims and methods
for each phase of instrument development.
Phase 1: Literature Review
A literature search was performed in Medline, using the key
words “continuity of care,” “co-ordination of care,” “patient
satisfaction,” and “cancer.” The purpose of the review was
twofold: 1) to identify deﬁnitions of “continuity and co-
ordination of care” applicable to secondary/tertiary hospital
care, and 2) to ﬁnd instruments that measure coordination and
continuity of medical care from patients’ perspective. The litera-
ture review did not identify any self-reported instruments suit-
able for hospital-based oncology practices. One instrument, the
CPCI, which was designed for use in primary health care, was
found to employ a useful taxonomy and included a number of
items and subscales that were of relevance to the cancer care
setting. This questionnaire consists of 19 items, organized into
four domains: “Patient preference to see usual doctor,” “Inter-
personal communication,” “Physician’s accumulated knowledge
of the patient,” and “Co-ordination of care.” The internal con-
sistency reliability of the four subscales ranged between 0.68 and
0.79. The instrument demonstrates good psychometric proper-
ties and was originally developed and evaluated in a sample of
2899 primary care patients visiting 138 family physicians’ ofﬁces
in the United States [8,9]. All items have a 5-point Likert scale
response format anchored by strongly agree and strongly dis-
agree. The way in which items are phrased requires patients to
report rather than rate their interaction with the physician.
Because cancer patients are typically reluctant to rate their phy-
sicians poorly [6], the less judgemental reporting style may serve
to reduce ceiling effects from responses.
Phase 2: Expert Review
While the CPCI provides a valuable scale structure and tax-
onomy, many items are phrased in a manner unsuitable for the
purposes of team-based hospital care. The CPCI was reviewed
for applicability to outpatient oncology by an expert panel of
three consultant medical oncologists and the experimenter
(GV), an oncologist in training. The experts were selected from
medical oncology and were chosen because they had experience
in managing team-based patient care across different cancer
specialities. A stepwise procedure (similar to the Delphi tech-
nique) was used to adapt the original CPCI and consensus was
reached for each decision to alter, remove, or add an item. The
ﬁrst step included a review of item content to determine appli-
cability to cancer patients. The second step examined the
wording of the remaining items and the ﬁnal step was item
generation to replace items that had been removed. See Table 2
for each modiﬁcation step. The modiﬁed questionnaire was
renamed the MCQ.
Phase 3 and 4: Evaluating the Psychometric Properties
of the New Instrument
In Phase 3, as part of an outpatient audit, 285 cancer
patients were invited to complete the new MCQ instrument
during their visit to the hospital or by post. Of those con-
tacted, 200 (70%) patients returned completed questionnaires.
For Phase 4, MCQ responses were collected from patients
taking part in two separate studies. The ﬁrst study was a
postal audit to determine patient experiences of their care;
313 cancer patients were contacted by post and asked to com-
plete and return the MCQ. Two hundred ﬁfteen (69%)
completed questionnaires were returned. The second study
was a randomized controlled trial (RCT) examining the
impact of routine quality of life assessment on patient–doctor
communication [10]. In this study, patients were asked to
complete the MCQ at baseline. Of the 286 cancer patients
who took part in the RCT, 262 (92%) completed the MCQ.
In total, 477 patients completed the MCQ questionnaire in
Phase 4.
The MCQ was administered at a regional hospital (North
England) with a specialist cancer service (Medical Oncology
Unit). The audits carried out in Phases 3 and 4 were performed
as part of a service improvement and as such were not subject to
NHS ethical approval. Adult patients from all tumor groups
attending the Medical Oncology Unit were eligible to take part in
Phases 3 and 4, provided they could read and understand English
and in the opinion of the investigator they were not exhibiting
overt cognitive dysfunction or signs of distress. The Phase 4 RCT
received NHS ethical approval and all patients gave written
informed consent before data collection in accordance with the
Declaration of Helsinki.
Table 1 Aims and methods for each study phase
Phase Year Aim Procedure
Phase 1 1999 Review literature relevant to continuity of care issues for
outpatient oncology and identify relevant instruments
1. Literature search
2. Review existing instruments
Phase 2 1999 Obtain expert opinion on the relevance of the CPCI and to
modify the instrument to be applicable to outpatient oncology
practice
1. Expert review of CPCI
2. Removal of incompatible items
3. Rewording existing items
4. Construction of new items
Phase 3 1999–2000 Test the acceptability and relevance of the adapted questionnaire
and explore its measurement properties
1. Patient completion of questionnaire
2. Descriptive analysis and modiﬁcation of questionnaire
3. Psychometric exploration of factor structure
Phase 4 2000–2003 Examine the hypothesized subscales in a new patient population.
Explore the validity of the modiﬁed questionnaire between
groups.
1. Patient completion of questionnaire
2. Patient completion of secondary instruments
3. Psychometric exploration of factor structure, reliability, validity,
and known groups
CPCI, Components of Primary Care Index.
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Demographic Details
For all studies in Phases 3 and 4, patient medical details, such as
the primary tumor site, were recorded from medical notes.
Patients completed a sociodemographic survey that included
details on the patients’ age, sex, marital status, and employment
status. Medical and social demographic details are summarized
in Table 3. Patients were predominantly female (81% in Phase 3;
74% in Phase 4) and diagnoses of gynecological, breast, and
genitourinary cancers were most common. The biases in distri-
bution of sex and diagnosis reﬂect the demographics of the unit,
with three specialized clinics in breast and gynecological cancers,
and one general oncology clinic.
Sample Size
For factor and multitrait analyses, sample size is typically rec-
ommended to require 5–10 times the number of participants as
the number of items included in the instrument [11]. In Phase 3,
the MCQ included 21 items and was completed by 200 patients,
giving a subject to item ratio of 9.5:1. In Phase 4, the MCQ
contained 15 items and was completed by 477 patients, giving a
subject to item ratio of 31.8:1.
Descriptive Analysis
In Phase 3, descriptive data were examined to assess the accept-
ability of each item to patients and to evaluate the contribution
of each item to the scale. Positively worded items on the MCQ
were reversed scored to be consistent with the remaining items.
After recoding, a lower score on each item indicated poorer
perception of continuity and coordination of care. Criteria for
retaining items included: 1) response ranges spanned three or
more response categories (i.e., categories 1 through to 4, or 2
through to 5 were selected); 2) mean values 4; and 3) no
ceiling effect, i.e., frequency of responses for less favorable
response categories should be >20%. Items not meeting these
criteria were removed before exploratory factor analysis (EFA)
because they were deemed likely to contribute to a ceiling
effect.
Table 2 Adaptation process of CPCI to MCQ showing item wording and factor loading of ﬁnal MCQ items
Original 19-item CPCI






I rarely see the same doctor when I go for medical care I rarely see the same doctor when I come to this clinic 1 0.403 1
Sometimes this doctor does not listen to me Sometimes the doctors do not listen to me 1 0.506 2
I want one doctor to coordinate all the health care I
receive
I want one doctor to coordinate all the care I receive 2 0.639 3r
This doctor communicates with the other health care
providers I see
The doctors I see in this clinic communicate with each
other
3 0.555 4r
This doctor do not always know my medical history
very well
The doctors do not always know my medical history and
problems very well
1 0.678 5
My medical care improves when I see the same doctor
that I have seen before
My medical care improves when I see the same doctor
that I have seen before
2 0.620 6r
It is very important to me to see my regular doctor It is very important to me to see my regular doctor 2 0.878 7r
This doctor and I have been through a lot together The doctors know how I feel emotionally while they are
treating me
3 0.785 8r
This doctor does not always know about care I have
received at other places
The doctors do not always know about the care and
treatment I have received previously in this clinic
1 0.677 9
I don’t always feel comfortable asking questions of this
doctor
I don’t always feel comfortable asking the doctors
questions
1 0.513 10
This doctor knows a lot about the rest of my family The doctors know about non-medical things in my life
(family, job, hobbies, social life)
3 0.642 11r
NEW I sometimes have to repeat my problems to the different
doctors I see in this clinic
1 0.506 12
NEW I would rather wait for the doctor who saw me last than
be seen by the next available doctor in clinic
2 0.736 13r
NEW The doctors usually know about the problems that have
bothered me at the previous visits
3 0.591 14r
I can easily talk about personal things with this doctor I can easily talk about personal things with the doctors 3 0.458 15r
How many years have you been a patient of this
physician?
REMOVED
I go to this doctor for almost all of my medical care REMOVED
If I am sick, I would always contact a doctor in this
ofﬁce ﬁrst
REMOVED
This doctor clearly understand my health needs The doctors clearly understand my medical needs REMOVED
This doctor knows the results of my visits to other
doctors
The doctors know the results of my previous visits to
this clinic
REMOVED
This doctor always follow up on a problem I’ve had,
either at the next visit or by phone
The doctors always follow up on a problem I’ve had
before
REMOVED
This doctor always explain things to my satisfaction The doctors always explain things to my satisfaction REMOVED
NEW The doctors I see in this clinic know what my treatment
or care plan is
REMOVED
NEW I don’t mind seeing different doctors because everyone in
the team knows my case
REMOVED
*The three factors were labeled as follows: factor 1, “Coordination” of medical information and doctor’s accumulated knowledge about patient; factor 2, “Preferences” to see usual doctor;
and 3, “Communication” with doctor.
r represents that the item has been reversed scored.
CPCI, Components of Primary Care Index; MCQ, Medical Care Questionnaire.
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Exploratory Factor Analysis
Kolmogorov–Smirnov tests showed the MCQ data in both
Phases 3 and 4 were not normally distributed (P < 0.05), there-
fore the latent structure of the instrument was examined using
principle axis factoring. Oblique (direct oblimin) rotation was
applied because the original CPCI reported that the factors
“coordination” and “accumulated knowledge” were correlated
[8] and correlations between factors were expected for current
data. The criteria for factor extraction were a minimum eigen-
value of 1.00 and that each component accounted for at least 5%
of the variance among items. Scree plots assisted the decision to
retain factors. Data with more than 40% missing values were
removed before analysis and remaining missing data were
replaced by mean values for the item.
Conﬁrmatory Factor Analysis
The suggested factor structure of the MCQ (from Phase 3 explor-
atory factor analysis) was examined using conﬁrmatory factor
analysis (CFA) with data in Phase 4. Goodness of ﬁt was deemed
acceptable if the chi-square value was low with a nonsigniﬁcant
P-value, and if the root mean square error of approximation
(RMSEA) was below 0.080.
Reliability
In Phase 4, the reliability of each subscale was examined using
multitrait analysis. This analysis examined the item-convergent
and item-discriminant validity of the subscales that were derived
from Phase 3 exploratory factor analysis and supported by Phase
4 CFA. Item-convergent validity was supported if items had
correlations >0.40 with their own hypothesized subscale. Item-
discriminant validity was supported if items correlated more
highly with their own hypothesized subscale than they did with
other subscales. The internal consistency reliability of each sub-
scale and the total scale was assessed by calculating Cronbach’s
alpha (a) coefﬁcients. Values above 0.70 were accepted as mod-
erate, while values above 0.80 were accepted as showing good
internal consistency.
Validity
In Phase 4, an objective measure of “continuity of care” was
derived to explore the external validity of the MCQ. The litera-
ture describes several indexes for continuity of care developed
mainly for family practice [12]. The simplest measure considers
the number of visits each patient has made and the number of
care providers seen, this is called the “K index” [13,14]. The K
index can be applied to a team-based hospital oncology practice
by recording the number of doctors each patient has seen and the
total number of clinic visits over time.
K index = (Number of Visits - Number of Doctors) /
(Number of visits - 1)
The K index has a value between 0 and 1. When a patient has
seen only one doctor over time, the K index will be 1. When a
patient has seen different doctors at each visit, the K index will
be 0.
The validity of the MCQ subscales was explored against
medical and demographic known groups. MCQ subscale scores
were derived by computing the mean of subscale items and
linearly transforming the data to a 0–100 scale. One-way analy-
sis of variance (ANOVA) tests (with Bonferroni corrections for
post hoc analyses) were carried out to determine any differences
in subscale scores for the following groups: diagnosis (breast,
genitourinary, gynecological, melanoma, sarcoma, or other); and
K index quartiles (quartiles were calculated using SPSS to identify
the score boundaries for the 25th, 50th, and 75th percentiles:
1st = 0–0.24; 2nd = 0.25–0.49; 3rd = 0.50–0.59; 4th = 0.60–
1.00). Independent samples t tests compared subscale scores
between age groups (less than or more than 60 years) and
between sexes.
Data were analyzed using SPSS version 16.0 for Windows
(SPSS Inc., Chicago, IL) and LISREL 8.80 Student (Scientiﬁc
Software International, Inc, Lincolnwood IL). The threshold for
statistical signiﬁcance was set at P < 0.05. Effect sizes for
ANOVAs (Cohen’s f ) were calculated using G*Power 3.0.10
[15]. Cohen’s f values are interpreted as small = 0.10, medium =
0.25, and large = 0.40 [16].
Results
Phase 2: Expert Review
Five items were removed from the original CPCI instrument
because they were not considered applicable to the cancer out-
patient population. Minor changes were made to eight items,
such as the replacement of “this doctor” with “the doctors” or
the addition of a few words to specify the setting, i.e., “this
clinic,” and major changes were made to two items. Seven new
items were added to the instrument, which covered aspects of
medical care speciﬁc to oncology and the system of delivery of
cancer care. The expert review resulted in a 21-item instrument
renamed the MCQ. See Table 2 for the expert review stages
including the original CPCI items and the adapted MCQ items.







Female 162 (81) 354 (74.2)
Male 38 (19) 123 (25.8)
Age group (years), n (%)
15–29 8 (4) 14 (2.9)
30–44 27 (13.5) 74 (15.5)
45–59 84 (42) 195 (40.9)
60–74 67 (33.5) 160 (33.5)
75+ 14 (7) 34 (7.1)
K index, median (range) 0.3 (0–1) 0.50 (0–1)
Marital status, n (%)
Single 12 (6) 30 (6.3)
Married/cohabiting 148 (74) 358 (75.1)
Divorced/widowed 37 (18.5) 84 (17.6)
Missing 3 (1.5) 5 (1.0)
Employment status, n (%)
Working full time 26 (13) 211 (44.2)
Working part time 23 (11.5) 43 (9.0)
On sick leave 51 (25.5) 58 (12.2)
Homemaker 16 (8) 40 (8.4)
Retired 76 (38) 112 (23.5)
Other 4 (2) 5 (1.0)
Missing 4 (2) 8 (1.7)
Diagnosis, n (%)
Breast cancer 53 (26.5) 112 (23.5)
Gastrointestinal 9 (4.5) 0
Genitourinary 33 (16.5%) 102 (21.4)
Gynecological 76 (38) 161 (33.8)
Melanoma 2 (1) 40 (8.4)
Sarcoma 11 (5.5) 36 (7.5)
Other 16 (8) 26 (5.5)
K index = (number of visits - number of doctors) / (number of visits - 1).
K index has a value between 0 and 1, when a patient has seen only one doctor over time K
index = 1.When a patient has seen different doctors at each visit, the K index = 0.
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Phase 3: Descriptive Analysis
The proportion of missing responses to the 21-item MCQ was
low (1–5%). Five items did not meet the criteria for retention
because they had high mean scores (range 4.4–4.5 across items)
and had a low cumulative frequency of less favourable responses
(range 9–12% across items). As such, these ﬁve items were
removed. One item (“I don’t mind seeing different doctors
because everyone in the team knows my case”) was deleted
despite meeting the criteria because it was a double statement
with ambiguous meaning. After descriptive analysis, the MCQ
instrument was reduced to 15-items. These remaining items were
subject to exploratory factor analysis.
Phase 3: Exploratory Factor Analysis and Reliability
Three factors were extracted with eigenvalues greater than 1 and
which accounted for at least 5% of variance in the data. Exami-
nation of the inﬂexion point of the Scree plot conﬁrmed the
retention of three factors. The 3 factors accounted for 45.47% of
the common variance and were labeled: “Coordination,” which
included items on the coordination of patient information and
accumulated physician knowledge about the patient; “Prefer-
ences,” which included items on patient preferences to see their
usual doctor; and “Communication,” which included items on
communication with doctors and knowledge about non-medical
issues. Each of the three subscales showed satisfactory internal
consistency (Cronbach’s alpha): Coordination a = 0.76; Prefer-
ences a = 0.83; and Communication a = 0.80. The subscale
scores were interpreted as follows: patients with higher “Com-
munication” and “Coordination” scores on the MCQ rated their
communication with doctors and coordination of their medical
information as better than patients with lower scores; patients
with higher “Preferences” subscale scores had a stronger prefer-
ence for seeing their usual doctor (or fewer doctors) during clinic
visits than patients with lower scores.
Phase 4: CFA
The three-factor model derived by EFA of the Phase 3 data was
examined in the Phase 4 data with CFA. We were concerned that
the Coordination subscale derived by EFA could have been an
artefact because the items contributing to this subscale were all
negatively worded. To determine whether the Coordination sub-
scale should be kept as an independent subscale or merged with
the Communication subscale, we compared the goodness of ﬁt of
two models. The ﬁrst model contained two factors: factor 1
combined all items from the Coordination and Communication
subscales and factor 2 contained the items from the preferences
subscale. The second model contained three factors, with the
items remaining within the three factors described in the Phase 3
EFA.
The two-factor model had poorer ﬁt than the three-factor
model. Goodness of ﬁt for two-factor model: c2 = 405.04;
df = 89; P = 0.000; RMSEA = 0.086; conﬁdence interval (CI)
of RMSEA = 0.078–0.095. The modiﬁcation indices suggested
adding paths between factor 1 (combined Coordination/
Communication subscale) and item 13; and paths between the
Preferences subscale and items 1, 2, 8, and 14. The three-factor
model showed improvement in goodness of ﬁt compared with the
2 factor model: c2 = 269.15; df = 87; P = 0.000; RMSEA =
0.066; CI of RMSEA = 0.057–0.075. The modiﬁcation indices
suggest adding a path between the Preferences subscale and item
1, and adding paths between the Communication subscale and
items 1 and 13.
Despite the improvement in ﬁt between the two-factor and
the three-factor models, the chi-square value remained high and
signiﬁcant. Nevertheless, the chi-square is often reported to be
inﬂated by large sample sizes, and the acceptable RMSEA score
for the three-factor model suggested adequate ﬁt of the 3 factor
model. The reliability of the three-factor model was explored
further with multitrait analyses, to determine whether any items
should be removed or moved from the three subscales.
Phase 4: Multitrait Item-Subscale Correlations
Data from Phase 4 were used to examine item-convergent and
item-discriminant validity of the 3 factor domain structure using
multitrait correlation analyses (Table 4). Items 1 and 10 showed
low item-convergent validity (0.36 for both items) with the Coor-
dination subscale but did not show higher correlations with other
subscales. Item 11 showed low item-convergent validity (0.38)
with the Communication subscale, but did not have a higher
correlation with any other subscale. Item 13 showed good item-
convergent validity with the Preferences subscale. The Coordi-
nation and Communication subscales were positively correlated
(r[469] = 0.45, P < 0.001). The internal consistency (Cronbach’s
alpha) for the three subscales was: Communication = 0.69; Pref-
erences = 0.84; and Coordination = 0.75. Cronbach’s alpha “if
item deleted” values were examined to determine whether the
subscales would be improved with the removal of items 1, 10,
and 11. Cronbach’s alpha for the Coordination subscale showed
no improvement for removing item 10 and showed only a small
improvement of 0.01 with the removal of item 1. Cronbach’s
alpha for the Communication subscale showed no improvement
with the removal of item 11. We decided to retain items 1, 10, 11,
and 13 in the original subscales, as suggested by Phase 3 EFA.
Phase 4: Known Groups Comparisons
Patients were divided into groups based on demographic and
medical details and their scores on the MCQ subscales were
compared (Table 5). Patients with breast cancer had lower Coor-
dination subscale scores (F[5468] = 2.53, P = 0.028, f = 0.16)
than patients with melanoma cancer but had higher Preferences
subscale scores (F[5451] = 3.75, P = 0.002, f = 0.20) than
patients with gynecological cancer. Breast cancer patients also
Table 4 Multitrait item-subscale correlations (phase 4)
MCQ Domains
Coordination Preferences Communication
Coordination — -0.292* 0.450*
1 0.362† 0.130 0.298
2 0.533† -0.242 0.302
5 0.562† -0.183 0.376
9 0.591† -0.231 0.353
10 0.361† -0.166 0.225
12 0.556† -0.225 0.356
Preferences -0.292* — -0.066*
3 -0.202 0.683† -0.034
6 -0.218 0.643† -0.009
7 -0.246 0.769† 0.009
13 -0.276 0.645† -0.139
Communication 0.450‡ -0.066* —
4 0.277 -0.118 0.418†
8 0.266 0.028 0.503†
11 0.235 -0.052 0.379†
14 0.344 0.019 0.504†
15 0.409 -0.102 0.472†
*Correlation between subscales (subscale values derived by computing the mean of subscale
items and linearly transforming the data to a 0–100 scale).
†Item correlation with own scale, corrected for overlap.
Items in italics (1, 10, 11) indicate low item-convergent validity with own subscale.
MCQ, Medical Care Questionnaire.
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had lower Communication subscale scores (F[5465]= 3.09,
P = 0.009, f = 0.18) than patients with gynecological (P = 0.027)
or melanoma (P = 0.050) cancers. Individuals with the highest K
index (4th quartile) had higher Preferences subscale scores
(F[3435] = 6.46, P = 0.000, f = 0.21) than patients from lower K
index quartile groups (1st quartile P = 0.083; 2nd quartile
P < 0.001; 3rd quartile P = 0.049). There were no between group
differences by K index quartile for Coordination or Communi-
cation subscale scores. There were no between group differences
in MCQ subscale scores for age group or sex.
Discussion
We have presented the various stages of development and vali-
dation of the MCQ, to measure oncology patients’ perceptions of
the continuity and coordination of their medical care and com-
munication with their doctors. The MCQ was adapted from the
CPCI by a process of expert review and psychometric evaluation.
This process led to a number of changes being made to the
original 19-item CPCI to make it applicable to an oncology
setting. This included removing or rewording items and generat-
ing new items. Although the item adaptation process was based
on consensus methods using expert reviewers, it could have been
improved by including patient opinions and feedback. Although
not reported in this study, patient feedback was elicited during
Phase 3. During this phase, patients were encouraged to
comment on the items and give feedback on the questionnaire.
Patient feedback was analyzed qualitatively and was taken into
consideration alongside the descriptive analysis. In summary,
most patients conﬁrmed the importance of the identiﬁed sub-
scales: many patients reported that it was important for them to
see the same doctor at each visit and that the coordination of
their medical information between individual doctors and the
wider medical team was very important to their care. The
adapted instrument was renamed the MCQ and contained 21
items.
Initial psychometric evaluation of the 21-item MCQ sug-
gested removal of ﬁve items that contributed to a ceiling effect in
responses. Of these items, two were from the original CPCI
questionnaire, two were adapted from the original CPCI, and
one was a new item. One additional new item was removed
because it was considered a double statement and was ambigu-
ous to interpret. The psychometric evaluation of the remaining
15 items suggested the MCQ measured three domains of conti-
nuity of care: “Communication” with doctors; “Coordination”
of medical information and physicians’ accumulated knowledge
about the patient; and “Preferences” to see usual doctor. The
“Preferences” subscale remained from the original CPCI, with
the addition of a new item (item 1) “I rarely see the same doctor
when I come to this clinic.” Subsequent evaluation of the hypoth-
esized domains in a new patient population showed that the three
subscales had reasonable internal and external reliability and
validity in the target population. While the item-factor structure
of the MCQ differs from the CPCI, the two instruments remain
conceptually similar in the measurement of patients’ preferences
to see their usual doctor, their evaluation of communication, and
their perception of the coordination of their medical information
between doctors. The differences in factor structure between the
two instruments might be expected given the removal of seven
original CPCI items and the addition of three new items to the
MCQ. The differences in factor structure may also be because of
differences in medical setting (primary versus secondary/tertiary
care) and the different patient population sampled in the current
study.
After item deletion in Phase 3, the 15-item MCQ was admin-
istered to a new oncology outpatient population in Phase 4. This
data were used to reexamine the hypothesized domain structure
and internal validity of the MCQ and examined its external
validity by comparing known groups. Although this second
administration of the 15-itemMCQ showed slightly poorer inter-
nal validity of the subscales than in the previous sample, each
subscale showed reasonable internal consistency and reliability,
and appears suitable for use in a mixed oncology outpatient
population.
The Communication domain of the MCQ is an element of
continuity of care that was not identiﬁed by Freeman et al. [5] as
being important to continuity of care. Nevertheless, in oncology,
it is important that the patients and doctors maintain good levels
of communication to enable the identiﬁcation of symptoms and
toxicities during treatment and to monitor the impact of disease
and treatment on broader social and psychological well-being.
The items in the Communication domain of the MCQ reﬂect the
importance of communication about nonmedical issues with
items such as: “The doctors know how I feel emotionally while
Table 5 Known group comparisons (phase 4)
Groups
Communication Coordination Preferences
n Mean SD P value n Mean SD P value n Mean SD P value
Sex *0.728 *0.985 *0.925
Male 121 70.80 16.86 121 69.22 22.23 117 67.20 25.78
Female 350 67.79 17.72 353 66.33 22.51 340 70.10 26.07
Age *0.907 *0.205 *0.396
<60 280 67.74 17.61 281 66.35 21.73 272 71.10 25.78
>60 191 69.78 17.42 193 68.11 23.48 185 66.80 26.17
Tumor group †0.009 †0.028 †0.002
Breast 110 63.17 18.66 111 63.03 23.30 106 77.44 21.56
Genitourinary 102 69.32 17.34 102 66.47 23.02 99 68.50 26.58
Gynecological 159 69.93 16.41 161 68.83 21.14 154 64.46 28.13
Melanoma 40 72.63 18.22 40 73.38 20.66 39 65.55 23.47
Sarcoma 34 69.60 17.87 34 65.77 22.71 34 68.57 26.49
Other 26 72.45 14.91 26 63.08 23.41 25 75.75 22.99
K index quartiles †0.079 †0.177 †0.000
0–0.24 103 64.94 17.04 104 64.77 22.59 102 67.97 25.34
0.25–0.49 117 69.46 18.36 117 65.25 22.90 112 62.78 28.40
0.50–0.59 72 67.88 17.70 72 70.30 21.36 69 66.21 26.80
0.60–1.00 161 70.53 17.19 162 69.34 22.20 156 76.02 22.79
*P-value from independent samples t test.
†P-value from one-way analysis of variance showing overall group effect.
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they are treating me,” “The doctors know about non-medical
things in my life,” and “I can easily talk about person things with
the doctors.” Among the patient groups, we found that patients
with breast cancer reported lower Communication scores than
patients with gynecological and melanoma cancers.
The Coordination domain of the MCQ was considered to
reﬂect patients’ experiences of continuity when they saw different
doctors for their medical care. Although we have given this
subscale the label Coordination, it is clear from the items
included in this domain that patients’ experiences of coordina-
tion are dependent on the quality of communication and the ﬂow
of information between health professionals and across clinic
visits. As may be expected, we found the Communication and
Coordination subscales were correlated. We explored combining
the two subscales, using CFA of phase 4 data, but this analysis
showed better model ﬁt when the factors Communication and
Coordination remained separate. In line with the correlation
between the two factors, we found that patients with breast
cancer reported lower Communication scores than patients with
gynecological and melanoma patients also reported lower Coor-
dination subscale scores than patients with melanoma cancer.
The Preferences subscale was considered to reﬂect the impor-
tance that patients place in seeing the same health professional at
each hospital visit. This has been identiﬁed in previous research
as an important component of continuity of care [4,5]. We found
a small negative correlation between the Preferences subscale and
the Coordination subscale, suggesting that those patients who
rated the coordination of their medical information between
doctors as poor might be more likely to place greater value in
seeing fewer health professionals for their medical care. In this
study, patients with breast cancer were more likely than patients
with gynecological cancer to endorse items from the Preferences
subscale. Perhaps counter intuitively we found that patients with
high K index values (who saw a fewer doctors per hospital visit)
were more likely to endorse items from the Preferences subscale.
This result may reﬂect that some clinics within the Medical
Oncology Unit endeavor to accommodate patients who have
strong preferences to see a particular doctor for their clinic visit.
It could be that a number of patients with higher scores on the
Preferences subscale were more active in ensuring their care was
delivered by particular health professionals.
There were several limitations to this study. Although we
believe our sample provided good representation of the patient
population seen in the Medical Oncology Unit, the majority of
the patients were female with breast or gynecological cancers and
the results may be biased toward female opinion. While the
comparison of MCQ subscales scores between males and females
did not show any signiﬁcant differences, further validation of the
questionnaire to include a larger number of men with cancer
would be desirable. Another limitation to generalized interpreta-
tion of the results is that the study phases 3 and 4 were carried
out in a single Medical Oncology Unit, part of a tertiary referral
cancer center. A typical feature of this setting is the large number
of doctors looking after the patients (teams of approximately 4–8
doctors), which was reﬂected in the relatively low K-index in our
study populations. Thus, further validation of the MCQ may be
required before it is applicable to hospitals where the oncology
care is delivered by a smaller team of doctors.
While the validity of the MCQ has been shown to be good in
a general cancer population, it is important that further work is
carried out to establish test–retest validity and to gather stronger
data on the relationship between patient scores and indicators of
clinical practice that are predicted to affect continuity of medical
care. Until the psychometric properties of the MCQ have been
validated further, we recommend that patient responses to the
MCQ are interpreted at the level of the three domains rather than
calculating a 15-item total score.
We have provided preliminary evidence that the MCQ instru-
ment can provide valuable information on patients’ experiences
of communicating with doctors and their perceptions of the
continuity and coordination of their medical care. The MCQ
instrument is brief (5–10 minutes to complete), easy to adminis-
ter, and is simple to score, therefore we feel it would be a valuable
and suitable patient-reported measure to be used in busy oncol-
ogy practice, clinical trials,and service improvement programs.
Source of ﬁnancial support: This study was funded by Cancer Research
UK C7775/A294. Data from this article have been presented in part at the
8th Annual Conference of the International Society for Quality of Life
Research (ISOQOL), November 7–10, Amsterdam, The Netherlands.
Booth, L, Selby, P, Lynch, P, Brown, J, Velikova, G. Measurement of
continuity and coordination of care in a cancer centre. Quality of Life
Research, 2001, 10 (3), 246 (Abstract No 212).
References
1 Blanchard CG, Ruckdeschel JC, Fletcher BA, Blanchard EB. The
impact of oncologists’ behaviors on patient satisfaction with
morning rounds. Cancer 1986;58:387–93.
2 Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of
provider behavior in medical encounters. Med Care 1988;26:
657–75.
3 Ong LM., de Haes JC, Hoos AM, Lammes FB. Doctor-patient
communication: a review of the literature. Soc Sci Med 1995;40:
903–18.
4 Freeman GK. Measuring continuity of care. Fam Pract 1987;
4:249–50.
5 Freeman G, Shepperd S, Robinson I, et al. Continuity of Care:
Report of a Scoping Exercise Summer 2000 for the SDO Pro-
gramme of NHS R&D. London: NCCSDO, 2001.
6 King M, Jones L, Richardson A, et al. The relationship between
patients’ experiences of continuity of cancer care and health out-
comes: a mixed methods study. Br J Cancer 2008;98:529–36.
7 Taenzer P, Bultz BD, Carlson LE, et al. Impact of computerized
quality of life screening on physician behaviour and patient sat-
isfaction in lung cancer outpatients. Psychooncology 2000;9:203–
13.
8 Flocke SA. Measuring attributes of primary care: development of
a new instrument. J Fam Pract 1997;45:64–74.
9 Flocke SA, Stange KC, Zyzanski SJ. The association of attributes
of primary care with the delivery of clinical preventive services.
Med Care 1998;36:AS21–30.
10 Velikova G, Booth L, Smith AB, et al. Measuring quality of life in
routine oncology practice improves communication and patient
well-being: a randomized controlled trial. J Clin Oncol 2004;
22:714–24.
11 Tabachnick BG, Fidell LS. Using Multivariate Statistics. Boston,
MA: Allyn and Bacon, 2001.
12 Ejlertsson G, Berg S. Continuity-of-care measures. An analytic
and empirical comparison. Med Care 1984;22:231–9.
13 Ejlertsson G. Assessment of patient/doctor continuity in primary
medical care. J R Coll Gen Pract Occas Pap 1980;7–10.
14 Ejlertsson G, Berg S. Continuity of care in health care teams. A
comparison of continuity measures and organisational solutions.
Scand J Prim Health Care 1985;3:79–85.
15 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a ﬂexible
statistical power analysis program for the social, behavioral, and
biomedical sciences. Behav Res Methods 2007;39:175–91.
16 Cohen J. Statistical Power Analysis for the Behavioral Sciences
(Revised ed.). New York: Academic Press, 1977.
1186 Harley et al.
